Dr. Davidson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7000 N Mopac Expy
Ste 420
Austin, TX 78731Phone+1 512-482-0045Fax+1 512-476-9892
Education & Training
Baylor College of MedicineResidency, Internal Medicine, 2002 - 2005
University of Texas Southwestern Medical SchoolClass of 2002
Certifications & Licensure
TX State Medical License 2005 - 2026- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants Start of enrollment: 2019 May 08
Publications & Presentations
PubMed
- 5 citationsA Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Invers...David H Margolin, Nicola L Brice, Antonia M Davidson, Kim L Matthews, Mark B L Carlton
The Journal of Pharmacology and Experimental Therapeutics. 2022-04-01 - 9 citationsA Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participa...Teodora Pene Dumitrescu, Samit R Joshi, Jianfeng Xu, Joyce Zhan, Mark Johnson
Antimicrobial Agents and Chemotherapy. 2021-05-18 - 10 citationsSiponimod pharmacokinetics, safety, and tolerability in combination with rifampin, a CYP2C9/3A4 inducer, in healthy subjects.Anne Gardin, Cathy Gray, Srikanth Neelakantham, Felix Huth, Antonia M Davidson
European Journal of Clinical Pharmacology. 2018-08-13
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
